Xenetic Biosciences, Inc. 8-K

What Happened
Xenetic Biosciences, Inc. filed an 8‑K on January 9, 2026 announcing that its 2025 Annual Meeting of Stockholders, originally scheduled for December 11, 2025, was adjourned to January 8, 2026 to achieve a quorum and solicit additional proxies. When the meeting was reconvened on January 8, 2026, it was again adjourned without any business being conducted due to lack of the requisite quorum. The company says it intends to reconvene the Annual Meeting at a later date (not yet determined) and will provide advance notice to stockholders.

Key Details

• Filing: Form 8‑K filed January 9, 2026 (Item 8.01 – Other Events).
• Original meeting date: December 11, 2025 (adjourned to January 8, 2026).
• Reconvened date: January 8, 2026 — meeting again adjourned without business due to lack of quorum.
• Next steps: Company will set and notify stockholders of a new meeting date; additional proxy solicitation was a stated reason for the adjournment.

Why It Matters
Because no quorum was present and no business was conducted, any shareholder votes or corporate actions scheduled for the Annual Meeting remain unresolved until the meeting is reconvened. Retail investors should watch for the company’s notice of the new meeting date and any further proxy solicitations, as those communications will indicate when outstanding votes will be taken.